NAMSW
NewAmsterdam Pharma Company N.V. WarrantNASDAQ
Updated 1 day ago
Coverage limited
$10.95-0.45%
Close Oct 13, 2026
- Market cap
- —
- 1 month
- —
- 3 months
- —
- 1 year
- —
- 52-week range
- $10.95$29.99
- Dividend
- No dividends on record
- Short interest
- 42 sharessettled Sep 30, 2026 · +2.4% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if NAMSW is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: HIGH
6 top institutions tracked
as of 2026-Q2 (filed 2026-08-14)
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
9 filers reported a long position in NAMSW for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $10.7M | 500.3K | Unchanged |
| RA CAPITAL MANAGEMENT, L.P. | $7.1M | 333.3K | Unchanged |
| Affinity Asset Advisors, LLC | $5.3M | 245K | Unchanged |
| Bain Capital Life Sciences Investors, LLC | $2.1M | 100K | Unchanged |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $2M | 92.8K | Unchanged |
| ARISTEIA CAPITAL, L.L.C. | $343.4K | 15.7K | Unchanged |
| WOLVERINE ASSET MANAGEMENT LLC | $318.9K | 14.9K | +601.7% |
| Vestcor Inc | $143K | 6.7K | Unchanged |
| UBS Group AG | $8.5K | 443 | +11.9% |
Get the Full Analysis for NAMSW
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.